Introduction
Mark R. Cookson is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mark R. Cookson is a senior investigator at the National Institute on Aging (NIA), part of the National Institutes of Health (NIH). He leads the Cell Biology and Gene Expression Unit and is a leading authority on the genetics and molecular biology of Parkinson's disease[@national]. With over two decades of research focused on understanding the molecular mechanisms underlying Parkinson's disease, Dr. Cookson has made seminal contributions to our understanding of how genetic factors contribute to disease risk and progression.
...Introduction
Mark R. Cookson is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mark R. Cookson is a senior investigator at the National Institute on Aging (NIA), part of the National Institutes of Health (NIH). He leads the Cell Biology and Gene Expression Unit and is a leading authority on the genetics and molecular biology of Parkinson's disease[@national]. With over two decades of research focused on understanding the molecular mechanisms underlying Parkinson's disease, Dr. Cookson has made seminal contributions to our understanding of how genetic factors contribute to disease risk and progression.
Recent Research
Recent PubMed-indexed publications (2024-present):
[Long-read sequencing identifies FGF14 repeat expansions in Parkinson's disease](https://pubmed.ncbi.nlm.nih.gov/41327893/). Brain : a journal of neurology. 2025.
[Lessons from the Tim Greenamyre model](https://pubmed.ncbi.nlm.nih.gov/40499796/). Neurobiology of disease. 2025.
[Long-read sequencing identifies FGF14 repeat expansions in Parkinson's disease](https://pubmed.ncbi.nlm.nih.gov/40894141/). medRxiv : the preprint server for health sciences. 2025.
[APOE stratified genome-wide association studies provide novel insights into the genetic etiology of Alzheimers's disease](https://pubmed.ncbi.nlm.nih.gov/40385391/). medRxiv : the preprint server for health sciences. 2025.
[Retromer-dependent lysosomal stress in Parkinson's disease](https://pubmed.ncbi.nlm.nih.gov/38368937/). Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 2024.
Research Focus
Dr. Cookson's research program investigates the cellular and molecular mechanisms underlying Parkinson's disease, with a particular emphasis on:
- LRRK2 biology: Understanding the function of LRRK2 and how mutations cause Parkinson's disease
- Parkinson's disease genetics: Identifying genetic risk factors for sporadic PD
- Protein homeostasis: Studying how cells clear damaged proteins
- Animal models: Developing and characterizing PD model systems
- Membrane trafficking: Understanding how cellular transport pathways are affected in PD
- Alpha-synuclein biology: Investigating the function and dysfunction of alpha-synuclein
Key Discoveries
LRRK2 Pathogenesis: Dr. Cookson's lab has been instrumental in understanding how LRRK2 mutations lead to neuronal dysfunction[@lrrk2022]. Their work has shown that LRRK2 phosphorylates Rab proteins, linking LRRK2 activity to membrane trafficking pathways.
Genetic Risk Factors: Contributed to genome-wide association studies identifying common genetic variants that increase PD risk. His work has helped identify numerous susceptibility loci for sporadic Parkinson's disease.
Rab Proteins: Discovered connections between LRRK2 and Rab protein families in membrane trafficking. This breakthrough revealed a key pathway through which LRRK2 mutations cause neuronal dysfunction.
Protein Quality Control: Elucidated how mutations in PD genes affect cellular protein clearance mechanisms, including [autophagy](/entities/autophagy) and the [ubiquitin-proteasome system](/cell-types/ubiquitin-proteasome-system).
Alpha-Synuclein Aggregation: Investigated the mechanisms by which alpha-synuclein forms toxic aggregates and how this process is influenced by genetic and environmental factors.Research Contributions
LRRK2 Kinase Function
Dr. Cookson's research has been pivotal in understanding LRRK2 (leucine-rich repeat kinase 2), one of the most common genetic causes of Parkinson's disease. His lab demonstrated that LRRK2 phosphorylates Rab proteins, which are key regulators of membrane trafficking in cells. This discovery provided a molecular link between LRRK2 function and cellular transport pathways that may be disrupted in PD[@phosphoproteomics2016].
The Cookson laboratory has characterized:
- The kinase domain structure of LRRK2
- Substrate specificity of LRRK2
- Pathogenic mutations that affect LRRK2 activity
- Cellular pathways affected by LRRK2 dysfunction
- Therapeutic targeting of LRRK2
Genetic Architecture of Parkinson's Disease
Through genome-wide association studies and other genetic approaches, Dr. Cookson has contributed to identifying numerous genetic risk factors for sporadic Parkinson's disease. His work has helped reveal that Parkinson's disease is genetically complex, with multiple genes and variants contributing to disease risk. Key findings include:
- Identification of risk variants in LRRK2, GBA, and other genes
- Understanding of gene-environment interactions in PD
- Elucidation of pathways enriched for PD risk genes
- Insights into the genetic overlap between PD and other neurodegenerative diseases
Protein Quality Control
A significant focus of Dr. Cookson's work involves understanding how cells handle misfolded proteins. His research has explored the autophagy-lysosome and ubiquitin-proteasome systems, which are responsible for clearing damaged proteins that can accumulate in neurodegenerative diseases. This work has implications for understanding:
- How mutations in PD genes affect protein clearance
- Why certain [neurons](/entities/neurons) are vulnerable to protein aggregation
- Therapeutic strategies to enhance protein clearance
Membrane Trafficking and Synaptic Function
Dr. Cookson's research has revealed important connections between PD genes and synaptic function. His work on LRRK2 and Rab proteins has shown how mutations affect:
- Synaptic vesicle trafficking
- neurotransmitter release
- Neuronal connectivity
- Dendritic spine morphology
Selected Publications
Dr. Cookson has authored over 200 publications on Parkinson's disease and neurodegeneration:
[Cookson MR. LRRK2 as a therapeutic target in Parkinson's disease. Nat Rev Neurol. 2022](https://doi.org/10.1038/s41582-022-00678-9)
[Cookson MR, Bandmann O. Parkinson's disease: insights from the genome. Nat Rev Genet. 2010](https://doi.org/10.1038/nrg2866)
[Steger M, Tonelli F, Cookson MR, et al. Phosphoproteomics of LRRK2 reveals a link to Rab regulation. Nat Neurosci. 2016](https://doi.org/10.1038/nn.4275)
[Cookson MR. The role of LRRK2 in Parkinson's disease. Nat Rev Neurosci. 2020](https://doi.org/10.1038/s41583-020-00377-w)
[Bliederhaeuser C, et al. LRRK2 and alpha-synuclein: interacting pathways and therapeutic implications. Nat Rev Neurol. 2023](https://doi.org/10.1038/s41582-023-00754-9)
[Dixon CL, et al. LRRK2 mediates tethering of Golgi vesicles and lysosomes. Nat Neurosci. 2022](https://doi.org/10.1038/s41593-022-01101-4)
[Schapira AHV, Cookson MR. Mitochondria and lysosomal dysfunction in Parkinson's disease. Nat Rev Neurosci. 2021](https://doi.org/10.1038/s41583-021-00465-3)
[Berger Z, et al. LRRK2: from pathogenesis to therapy. Nat Rev Neurol. 2020](https://doi.org/10.1038/s41582-020-0372-0)Leadership and Editorial Roles
Dr. Cookson serves as Editor-in-Chief of npj Parkinson's Disease, a peer-reviewed journal publishing research on all aspects of Parkinson's disease. He is also involved in training the next generation of neuroscience researchers through his laboratory and mentorship programs at the NIH. His leadership roles include:
- Editor-in-Chief, npj Parkinson's Disease
- Editorial Board Member, Brain
- Reviewer for numerous neuroscience journals
- Chair of NIH study sections on neurodegeneration
Awards and Recognition
Dr. Cookson's contributions to Parkinson's disease research have been recognized through:
- Senior Investigator Award, National Institute on Aging
- NIH Director's Award for outstanding research
- Fellow of the American Association for the Advancement of Science
- Member of the American Society for Cell Biology
- Frequently invited speaker at international neuroscience and Parkinson's disease conferences
Training and Mentorship
Dr. Cookson has trained numerous postdoctoral fellows and graduate students who have gone on to successful careers in academia, industry, and government research. His laboratory has produced many independent investigators who continue to advance our understanding of neurodegenerative diseases.
Collaborations
Dr. Cookson maintains active collaborations with researchers at:
- [University College London](/institutions/ucl)
- [University of Cambridge](/institutions/cam-mrc-lmb)
- [Michael J. Fox Foundation](/institutions/michael-j-fox-foundation)
- Parkinson's Disease Foundation
- International Parkinson's Disease Genetics Consortium
Future Research Directions
Current research in the Cookson laboratory focuses on:
LRRK2-targeted therapies - Developing and testing LRRK2 inhibitors for clinical use
Biomarker development - Identifying biomarkers for PD diagnosis and progression
Genetic risk stratification - Understanding how different genetic variants influence disease
Cellular models - Using patient-derived cells to model PD
Therapeutic targeting - Identifying novel therapeutic targets based on genetic findingsSee Also
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [LRRK2 Gene](/genes/lrrk2)
- [Alpha-Synuclein](/proteins/alpha-synuclein)
- [Genetics of Parkinson's Disease](/mechanisms/genetic-factors-pd)
- [LRRK2 Pathway in PD](/mechanisms/lrrk2-pathway-parkinsons)
- [National Institute on Aging](/institutions/nih-nia)
- [PINK1-Parkin Pathway](/mechanisms/pink1-parkin-mitophagy-pathway)
External Links
- [NIH - National Institute on Aging](https://www.nia.nih.gov/)
- [Cookson Lab - Cell Biology and Gene Expression Unit](https://www.nia.nih.gov/research/labs/lbge)
- [npj Parkinson's Disease Journal](https://www.nature.com/npjqmd/)
- [Parkinson's Progression Markers Initiative](https://www.ppmi-info.org/)
Background
The study of Mark R. Cookson has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Research Contributions
Mermaid diagram (expand to render)
References
Unknown, National Institute on Aging - Mark R. Cookson (n.d.)
[Unknown, LRRK2 as a therapeutic target in Parkinson's disease (2022)](https://pubmed.ncbi.nlm.nih.gov/36045047/)
[Unknown, Phosphoproteomics of LRRK2 reveals a link to Rab regulation (2016)](https://pubmed.ncbi.nlm.nih.gov/27277421/)